Generic Keppra Information and Warnings

Keppra and its generic version Levetiracetam are anti-epileptic drugs (AEDs) used in the treatment of seizures in epileptic adults and children. After studies began to reveal some of the severe side effects caused by these AEDs, the FDA recommended to a panel of experts that Keppra (in addition to other anti-epilepsy drugs) be required to place a Black Box warning informing users of the serious side effects. According to the studies, the drug nearly doubled the risk of suicide as compared to placebos. However, the panel of experts determined that the Black Box warning was too extreme and that an increased warning was sufficient. Black Box warnings were not placed on Keppra because the experts feared that this would deter patients who really needed the drug from taking it.

Generic Substitution of AEDs Strongly Opposed by Epilepsy Foundation and Others

However, the FDA has only focused on the possible side effects of taking AEDs like Keppra and Levetiracetam. The FDA has not issued any information or warnings regarding the increased risk of seizures and side effects when epilepsy patients switch from brand name Keppra to Levetiracetam, despite the fact that the Epilepsy Foundation and the American Academy of Neurology have strongly opposed generic substitution and attempted to bring the documented problems to the attention of doctors, pharmacists, insurers, and the FDA.

Have you or a loved one suffered as a result of switching from brand name Keppra to generic Keppra (Levetiracetam)? If so, you should seek legal help immediately to protect your rights. While there is no fee or obligation, delaying may mean you could lose your right to seek compensation for injuries caused by your switch to generic Keppra, due to state-imposed time limits for filing a lawsuit.

Check out the following articles for more information about generic Keppra, filing a generic Keppra lawsuit and finding a generic Keppra attorney.

Make it Social